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Background: Physical activity has become part of the therapy of patients with cystic fibrosis (CF) despite possible risks. The objectives of this
study were to identify predictors of hypoxemia and to search for cardiac arrhythmia during exercise.
Methods: The data of 75 patients (12 to 41 years old) with CF who underwent a standardized incremental exercise test on a cycle ergometer was
analyzed. Oxygen saturation (SpO2) and ECG were monitored. The results were related to spirometric and SpO2 measurements at rest.
Results: During exercise, 17 patients suffered from significant desaturations (SpO2b90%). SpO2 at peak exercise was independently related to
SpO2 at rest and 1/FEV1 (multiple regression R
2=0.63). Five patients demonstrated ventricular arrhythmias during exercise. No unambiguous
prediction of exercise-induced hypoxemia or cardiac arrhythmia was possible.
Conclusion: In order to detect all patients with exercise-induced hypoxemia and cardiac arrhythmia, an incremental exercise test to volitional
fatigue must be performed.
© 2008 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cardiac arrhythmias; Cardiopulmonary exercise testing; Cystic fibrosis; Hypoxemia; Oxygen saturation1. Background
Physical activity and exercise conditioning have become
increasingly important in the treatment of patients suffering from
cystic fibrosis (CF). Several studies have shown that these patients
benefit from physical activity with respect to exercise capacity,
pulmonary function, muscle mass, and quality of life [1–4].
Furthermore, physical fitness is associated with a higher life
expectancy [5] and better performance in professional life [6].
Many potential risks, though, have been associated with
physical exertion in patients with CF, such as exercise-induced
hypoxemia and bronchoconstriction, pneumothorax, hypogly-
cemia, rupture of oesophageal varices or spleen, and fractures
[7,8]. In addition, pulmonary exacerbations have been reported
after winter sport [9]. Of all the risks mentioned, exercise-
induced hypoxemia has been studied most systematically.
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exercise test up to volitional fatigue. Although patients with
advanced pulmonary disease were most at risk for exercise-
induced hypoxemia, no reliable prediction of the decrease in
oxygen saturation could be made from the patients' pulmonary
function at rest. In a smaller sample of 21 patients, Lebecque
et al. [11] found that six patients with a FEV1 between 17 and
28% predicted and with an impaired single-breath diffusion
capacity for carbon monoxide showed a significant exercise-
induced hypoxemia (b90%) while the remaining patients with a
FEV1 greater 36% and a diffusion capacity greater 83% did not.
Studies validating pulse oximeters to assess oxygen saturation
during exercise have demonstrated that some systems have a
large measurement error [12]. Thus, by using a precise and
validated pulse oximeter, the relationship between resting
pulmonary function and oxygen saturation during exercise
might become much clearer.
Studies in patients with chronic obstructive pulmonary
disease (COPD) have shown that low oxygen saturation during
exercise may predispose to cardiac ventricular dysrhythmia
[13], possibly due to cor pulmonale, acid–base disturbances andd by Elsevier B.V. All rights reserved.
Table 1
Subjects' characteristics
Female patients (n=36) Male patients (n=38)
Age (years) 19.8±6.9 (12.0–41.6) 21.8±6.9 (12.3–41.3)
Height (m) 1.61±0.73 (1.41–1.76) 1.70±0.12 (1.38–1.90)⁎⁎⁎
Weight (kg) 52.1±9.3 (36.5–73.8) 59.2±14.7 (30.5–95.1)⁎⁎
FVC (%pred) 80.3±21.4 (35.8–116.3) 79.7±23.7 (33.1–122.2)
FEV1 (%pred) 67.6±25.4 (22.3–121.7) 63.0±26.0 (23.2–104.1)
RV (%pred) 152.3±61.3 (64.0–306.3) 168.1±68.3 (63.5–360.0)
RV/TLC (%) 39.9±12.6 (18.8–60.5) 39.7±12.2 (17.4–73.0)
SpO2 at rest (%) 97.3±2.2 (92–100) 97.2±2.2 (90–100)
Data is presented as mean±standard deviation (range). Abbreviations: FVC—
forced vital capacity; FEV1— forced expiratory volume in 1 s; RV— residual
volume; TLC— total lung capacity; %pred— % of predicted. ⁎⁎Significantly
different from female patients (pb0.01); ⁎⁎⁎Significantly different from female
patients (pb0.001).
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could not find any report of exercise-induced arrhythmias in
patients with CF, although the same risk factors observed in
COPD have also been found in CF. There is, however, evidence
for cardiac involvement with manifestation during exercise in
CF. De Wolf et al. [16] studied left ventricular perfusion during
exercise in 18 patients with CF. Among these, six showed
defects in perfusion. Interestingly, one of these six patients did
not suffer from oxygen desaturation during exercise, whereas
five developed exercise-induced hypoxemia. In four of the six
patients, cardiac perfusion was also evaluated at rest and was
found to be normal. The authors speculated that either an
insufficient blood supply to the myocardium and/or regional
myocardiopathy were responsible for the perfusion anomalies.
Further reports indicate fibrotic changes in the myocardium of
patients with CF [17,18]. Anyhow, neither De Wolf et al. [16]
nor any of the other studies we could find report on arrhythmias
during exercise in CF. Despite this missing evidence, we
hypothesized that exercise-induced cardiac dysrhythmia does
occur in patients with CF and that exercise-induced hypoxemia
would be a risk factor.
Consequently, the objective of this retrospective study was
first to identify the prevalence of exercise-induced hypoxemia
in a group of patients with CF varying in age and disease
severity using validated methodology. We then intended to
identify predictors of exercise-induced hypoxemia. Finally, we
especially searched for the prevalence of exercise-induced
cardiac dysrhythmia and tried to identify potential risk factors.
2. Methods
In order to investigate the prevalence of exercise-induced
hypoxemia and dysrhythmia, the exercise tests of 75 CF
patients (36 females and 39 males) between 12 and 41 years of
age were retrospectively analyzed. These patients were tested
between 1999 and 2007 using identical equipment and testing
protocols for yearly routine check-ups (n=18) or as part of
scientific studies (n=57). The written informed consent of all
patients was obtained; the scientific studies had been approved
by the local ethics committee. Some of these patients' data have
been included in another publication [4].
On the testing day, the patients first completed a lung
function test, assessing forced expiratory volume in 1 s (FEV1),
forced vital capacity (FVC), residual volume (RV), and total
lung capacity (TLC) (Masterscreen Body, Jaeger, Würzburg,
Germany). Data were expressed as % predicted. The subjects'
characteristics are shown in Table 1.
After familiarizing the patients with the exercise testing
equipment, incremental exercise tests were carried out accord-
ing to the Godfrey protocol [19] on a cycle ergometer
(Ergomedic 834 E, Monark, Sweden). Work rate was selected
depending on the height of the patient: patients with a height
between 120 and 150 cm started with 15 W, patients taller than
150 cm started with 20 W. Work rate was increased minute-by-
minute by 15 W or 20 W, respectively, up to volitional fatigue.
Physical working capacity was determined as the highest work
rate performed for 1 min and expressed in % predicted [19].During exercise, ventilation and gas exchange data were
obtained breath-by-breath using a metabolic cart, and averaged
every 15 s (CPX/D, MedGraphics, St. Paul, MN, USA). Peak
oxygen uptake (VO2peak) was taken as the highest oxygen
uptake over two consecutive 15-s intervals during the test and
expressed in % predicted [20]. The respiratory exchange ratio
(RER) at peak exercise was determined for the same time
interval as VO2peak.
Before, during and at least 3 min following exercise, a 12-
lead ECG was recorded (custocard m, Ottobrunn, Germany).
The chest electrodes were placed in standard positions, the limb
electrodes were placed supraclavicular near the shoulders and
suprailiac [21]. Ectopic cardiac beats and cardiac arrhythmias
were searched for by visually inspecting the entire ECG.
Exercise-induced cardiac arrhythmias were defined as ectopic
beats occurring 1) only during exercise and 2) with increasing
frequency when exercise intensity rose.
Oxygen saturation (SpO2) was monitored before and during
the exercise test using pulse oximetry with a forehead sensor
(Nellcor Reflectance oxygen sensor RS10, Nellcor Puritan
Bennet Inc., Pleasanton, CA, USA). By comparison with
arterial blood samples, Yamaya et al. [12] could show that this
system revealed accurate measurements. Exercise-induced
oxygen desaturation was defined as a drop in SpO2 of more
than 4% from resting values to peak exercise [22]. Significant
hypoxemia was assumed if SpO2 fell below 90%, since it has
been suggested to limit the intensity of activities in patients who
experience SpO2 values below this threshold [23].
In our CF centre, echocardiography is performed routinely
once a year. Hence, many but not all of the patients enrolled in
this study had echocardiographic examinations around the time
of the exercise test. We were retrospectively able to analyze the
echocardiographies of 44 patients, among these all those
patients who had shown ectopic beats in the ECG during the
exercise-testing.
3. Data analysis
Differences between groups of patients (male vs. female;
arrhythmia vs. no arrhythmia) were assessed by Student t-tests.
Correlation analyses according to Pearson were used to assess
Table 2
Peak performance during the exercise test, and heart rate and gas exchange data
at peak exercise
Female patients (n=36) Male patients (n=39)
Maximal aerobic
power (Watt/kg)
2.60±0.68 (0.92–3.75) 3.12±0.70 (1.48–4.25)⁎⁎
Maximal aerobic
power (%pred)
93.7±28.1 (30.6–159.4) 93.1±22.8 (40.6–131.3)
VO2peak
(ml min−1 kg−1)
32.2±7.2 (19.5–49.6) 38.8±8.4 (20.6–54.8)⁎⁎
VO2peak (%pred) 80.1±20.2 (47.2–124.0) 75.5±16.5 (37.6–110.1)
Heart rate (min−1) 173.1±16.5 (110–201) 177.6±14.6 (149–202)
RER 1.15±0.13 (0.91–1.39) 1.14±0.12 (0.90–1.35)
SpO2 (%) 93.5±6.9 (71–100) 92.1±6.0 (73–99)
Data is presented as mean±standard deviation (range). Abbreviations: VO2peak—
peak oxygen uptake, RER— respiratory exchange ratio, SpO2— oxygen saturation;
%pred—% of predicted. ⁎⁎Significantly different from female patients (pb0.01).
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SpO2 at peak exercise) and variables obtained at rest. A multiple
linear regression analysis entering non-exercise data as possible
predictors was used to establish an equation to estimate SpO2 at
peak exercise. The following parameters were tested as
correlates of the exercise-induced change in SpO2, or peak-
exercise SpO2, and were allowed to enter the multiple linear
regression model as independent predictors of peak-exercise
SpO2: age, height, weight, SpO2 at rest, FEV1, FVC, MEF25,
RV, TLC, and RV/TLC. For the multiple linear regression
model, gender and 1/FEV1 were also assessed as possible
predictors of peak-exercise SpO2.
Statistical analyses were performed using BMDP Dynamics
(BMDP Statistical Software, Cork, Ireland). Statistical sig-
nificance was assumed if the probability of the type 1 error was
below 5% (pb0.05).
4. Results
Table 2 summarizes peak performance data, and heart rate,
SpO2, and gas exchange data obtained at maximal exercise.Fig. 1. Relationship between (A) SpO2 at rest and SpO2 at peak exercise, (B) betwee
exercise.We observed a drop in oxygen saturation of more than 4%
in 23 patients (31%). Among these, 17 patients (23% of the
total sample) experienced a significant hypoxemia (SpO2
below 90%) and 4 of those had a SpO2 at peak exercise below
80%. All patients with a FEV1 above 70% predicted did not
show any significant exercise-induced hypoxemia. Those 4
patients who had a minimum SpO2 below 80% all had a FEV1
below 40% predicted. 7 of 65 patients with a FEV1 of more
than 50% FVC experienced a drop in SpO2 below 90%, while
all patients with a FEV1/FVC below 50% showed significant
exercise-induced hypoxemia. One patient with an exercise-
induced drop in SpO2 to 87% had a FEV1 corresponding to
86% of FVC.
Correlation analyses revealed significant relationships
between the exercise-induced drop in SpO2 and the following
variables: SpO2 at rest (r=0.47, pb0.001), FEV1 (r=0.59,
pb0.001), FVC (r= 0.52, pb0.001), MEF25 (r=0.43,
pb0.001), RV (r=−0.31, pb0.01) TLC (r=0.27, pb0.05),
and RV/TLC (r=−0.45, pb0.001).
The same variables were also found to be related to SpO2 at
peak exercise: SpO2 at rest (Fig. 1A, r=0.72, pb0.001), FEV1
(Fig. 1B, r=0.66, pb0.001), FVC (r=0.59, pb0.001), MEF25
(r=0.47, pb0.001), RV (r=−0.38, pb0.01), TLC (r=0.31,
pb0.01), and RV/TLC (r=−0.51, pb0.001). Since the relation-
ship between SpO2 at peak exercise and FEV1 appeared to be
non-linear (see Fig. 1B), a transformation of FEV1 (1/FEV1)
was also used and proved a stronger correlate of SpO2 at peak
exercise than FEV1 itself (Fig. 1C).
Using multiple linear regression analysis, only SpO2 at rest
and 1/FEV1 were identified as independent predictors of SpO2
at peak exercise. The equation to estimate SpO2 at peak exercise
resulting from this analysis was:
SpO2 at peak exercise in kð Þ ¼ 16:4875
309:1474=FEV1 in % predictedð Þ
þ1:1825TSpO2 at rest in kð Þ;R2 ¼ 0:63
This equation had a high sensitivity and specificity (82%
and 95%, respectively) to predict an exercise-inducedn FEV1 and SpO2 at peak exercise, and (C) between 1/FEV1 and SpO2 at peak
Fig. 2. Performance of a formula to predict peak exercise SpO2 using SpO2 at rest and 1/FEV1 as independent predictors. A) Relationship between predicted SpO2 at
peak exercise and observed SpO2 at peak exercise. The continuous line indicates the line of identity, the dashed lines a SpO2 of 90%. The numbers in the four quadrants
of the graph represent the number of patients with the respective SpO2 values above or below 90%. B) Bland-Altman plot of residual SpO2 at peak exercise
(SpO2measured–SpO2predicted) over SpO2 at peak exercise predicted using SpO2 at rest plus 1/FEV1 as predictors. The continuous line indicates the mean residual,
the dashed lines the 95%-confidence interval.
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the 17 patients with a SpO2 at peak exercise below 90% were
not identified from the prediction equation and Bland-Fig. 3. ECG recordings obtained at rest and at peak exercise from two patients with
A) Female patient, 18-years-old, FEV1: 22.3% predicted, SpO2 at rest: 92%, SpO2 at
at rest: 95%, SpO2 at peak exercise:86%.Altman plots revealed that the prediction equation consider-
ably overestimates SpO2 at peak exercise in some patients
(Fig. 2B).CF. Both patients developed severe exercise-triggered ventricular arrhythmia.
peak exercise: 74%. B) Male patient, 40-years-old, FEV1:23,2% predicted, SpO2
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beats during exercise (see Fig. 3). Interestingly, the two patients
with the most severe ventricular arrhythmia shown in Fig. 3 had
very poor lung functions. In all five patients, resting ECG was
normal without signs of pre-excitation syndrome, long QT-
syndrome or right heart stress. The arrhythmias started during
the exercise test at a heart rate ranging from 103 to 167 min−1
and at a SpO2 between 86% and 95%. None of the patients
showed a N3 beat run and in all patients, the arrhythmias
remained asymptomatic. Heart rhythm normalized within
15 min after the end of exercise. When comparing the
characteristics of these five patients with exercise-triggered
ventricular arrhythmia to those of the patients without
arrhythmia the patients with arrhythmia had a significantly
lower SpO2 at rest and peak exercise and a lower VO2peak but
did not differ significantly in height and weight, lung function
(FEV1 % predicted, FCV % predicted, RV% predicted, RV/
TLC) and maximum power (Watt).
Echocardiographic results were available in 44 patients,
among these all 5 patients who showed cardiac arrhythmias
during exercise. In three of these, echocardiographic studies at
rest showed signs of right heart stress, which were, however,
also observed in 4 patients without exercise-induced cardiac
arrhythmias.
Two additional patients suffered from ectopic ventricular
extra systoles at rest which disappeared during exercise. One
clinically asymptomatic 37-year-old patient was diagnosed to
suffer from a pre-excitation (Wolff–Parkinson–White) syn-
drome, without showing any irregularities of cardiac rhythm at
rest or during exercise-induced stress.
5. Conclusions
This study shows that exercise-induced hypoxemia occurs in
a considerable number of patients with CF. Furthermore, 23% of
the patients studied experienced a significant drop in SpO2
below 90% during exercise, a finding which might warrant
exercise restrictions in these patients [23]. In line with our
findings, Lebecque et al. [11] reported a prevalence of exercise-
induced hypoxemia of 26% in 21 patients. However, Henke et
al. [10] observed a lower prevalence of exercise-induced
hypoxemia more than 20 years ago (10%). These differences
among studies might be due to differences in the patients'
characteristics studied, i.e. the patients' age, and the fact that
patients nowadays are likely to be more physically active and
can perform exercise at higher work rates, thereby inducing
more profound changes. Moreover, we used a forehead sensor
to determine SpO2 while Henke et al. [10] as well as Lebecque
et al. [11] employed an ear sensor. In comparison with finger
sensors, the forehead sensor has proven to provide more valid
readings during exercise [12] which might have enabled us to
discover hypoxemia more precisely.
Based on the data of 21 patients, Lebecque et al. [11] stated
that dangerous exertional desaturations are most unlikely, if
FEV1 is greater than 35% predicted while FEV1 in percent of
FVC was no useful predictor. Henke et al. [10] concluded that
no reliable information with respect to exercise-inducedhypoxemia can be drawn from pulmonary function testing.
However, in their study, patients with a FEV1% above 50% of
forced vital capacity did not suffer from an exercise-induced
drop in SpO2 below 90% which might lead to the assumption
that patients with a better lung function are less at risk for
exercise-induced hypoxia. Indeed, Henke et al. [10] suggested
that mainly those patients with a FEV1 less than or equal to 50%
of FVC require regular exercise-testing. In the present study,
though, about 10% of the patients with a FEV1 above 50% FVC
experienced significant hypoxemia with exercise. Thus, the
recommendations of Henke et al. [10] need to be extended to
patients with less severe lung disease. Data from our study
suggest including at least all patients with a FEV1 below 70%
predicted or with a FEV1 below 90% of FVC, as we found
significant drops of oxygen saturation (below 90%) even in 2
patients with and FEV1 between 70% and 90% of FVC.
Previous studies have shown that peak exercise SpO2 is
related to FEV1 and resting SpO2 in patients with CF
[10,11,24]. The present study reproduced these findings and
identified other lung function parameters as additional corre-
lates of peak exercise SpO2. We employed multiple linear
regression analysis to improve the identification of patients who
will significantly desaturate during exercise. Although a high
sensitivity and specificity of the resulting prediction equation
was observed, some of the patients who had significant
hypoxemia during exercise were not identified. Thus, as with
previous attempts to identify patients at risk for exercise-
induced hypoxemia using measurements obtained at rest, the
approach employed in this study does not provide an acceptable
sensitivity at a high level of specificity.
In a group of 21 patients, Lebecque et al. [11] observed that
patients with a diffusion capacity for carbon monoxide (DCO)
above 80% predicted did not suffer from desaturations during
exercise-testing. In the present study, DCO was not measured.
However, although we cannot exclude that the additional
measurement of DCO might have added to our prediction
model, this seems unlikely for the following reasons: 1) Lebeque
et al. [11] and others [25] reported a strong correlation between
FEV1 and DCO in CF, so that one of the variables may most
likely be substituted by the other in multiple regression analysis.
2) In contrast to the study by Lebecque et al. [11] some of our
patients with a FEV1 greater than 35% and up to 68% showed a
drop in oxygen saturation below 90%. Thus, it is quite likely that
patients with less severe pulmonary disease than those reported
by Lebecque et al. [11] will experience significant exercise-
induced hypoxemia.
To our knowledge, this study is the first to report on exercise-
triggered ventricular arrhythmias in patients with CF. The
prevalence of this potentially hazardous side effect of physical
exertion was 5/75 patients or 6–7% of all patients tested. In
presumably healthy children and adults, exercise-induced
ventricular ectopic activity is extremely rare with a prevalence
b1% [26,27].
In patients with severe COPD, Cheong et al. [14] observed a
much higher prevalence of ventricular arrhythmia (19.7%)
compared with the present study. There are several possible
explanations for the different findings in the two studies: The
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1.1% predicted while most of our patients had a far better
pulmonary function. Furthermore, the patients with COPD were
considerably older than the patients with CF in the present
study. It has been shown that the prevalence of exercise-induced
ventricular arrhythmias increases with age [28].
In line with our hypothesis that exercise-triggered ventricular
arrhythmia would be related to exercise-induced hypoxemia,
our five patients with this form of cardiac arrhythmia had
significantly lower SpO2 at rest and at peak exercise compared
with the patients who showed no cardiac dysrhythmia with
exercise. However, only three of the five patients demonstrated
a drop in SpO2 below 90% with exercise and only four patients
dropped their SpO2 by more than 4%. Using the prediction
equation for peak-exercise SpO2 developed in this project, two
of the five patients with exercise-triggered cardiac arrhythmia
had a SpO2 of N90%predicted. As to their lung function, three
of the five patients had a FEV1b50% predicted, whereas the
remaining two had relatively mild lung disease with a FEV1
between 60% and 70% predicted. Standard echocardiography at
rest also could not clearly discriminate between patients who are
at risk for exercise-induced arrhythmia. Thus, it seems
impossible to identify all patients with exercise-induced cardiac
arrhythmia using solely measurements taken at rest.
The five subjects in our study did not show any clinically
relevant symptoms caused by the exercise-induced arrhythmias.
Furthermore, no exercise test had to be terminated according to
the actual guidelines (increasing ventricular ectopy including a
N3 beat run in children [29] or angina or sustained ventricular
tachycardia in adults [30]). As to the clinical consequences of
the cardiac arrhythmias for exercise recommendations, no clear
evidence-based statement can be made since no reports on
exercise-related cardiac deaths could be found in patients with
CF. In patients with coronary artery disease causing myocardial
ischemia — possibly one reason for the exercise-induced
arrhythmias also in CF patients with low oxygen saturation— a
bigeminus as observed in one of our patients (Fig. 3A) or
couplets of ectopic beats in another (Fig. 3B) are associated
with a more frequent occurrence of myocardial infarction [31].
Cheong et al. [14] looked at cardiac arrhythmias in patients with
COPD and concluded that potentially serious arrhythmias
would be uncommon in these patients if they did not have
clinically significant arrhythmias at rest. Nevertheless, in our
patients we recommended to limit exercise intensity to levels
with no arrhythmias. In one patient with severe exercise-
induced hypoxemia and ventricular arrhythmias, supplemental
oxygen during exercise also proved effective. None of the five
patients with exercise-induced arrhythmias died during or
shortly after exercise or of sudden cardiac problems after a 2- to
5-year follow-up.
We have shown in this study that a considerable proportion
of patients with CF experience significant hypoxemia and
cardiac arrhythmia during exercise. As shown above, those
patients at risk are not easily identified from assessment at rest.
Based on our data, we recommend performing exercise testing
at least in patients with a FEV1 below 70% predicted, if not in
all patients old enough to undergo standardized testing, asmonitored exercise-testing is the only means to unambiguously
discover exercise-induced hypoxia and cardiac arrhythmia.
These tests should be carried out according to current guide-
lines. Although our data are by no means a proof for exercise-
limitations if ventricular arrythmias are detected during testing,
we recommend to either limit maximal exercise intensity or to
use additional oxygen in order to keep the patients physically
active.
Data was presented as poster at the 102nd annual meeting of
the German Society of Pediatrics and Adolescent Medicine
(Deutschen Gesellschaft für Kinder- und Jugendmedizin) in
Mainz/Germany in September 2006.
Fahrradergometrie zur Erfassung von Risiken körperlicher
Belastung bei Mukoviszidose
K. Ruf, H. Hebestreit
Universitäts-Kinderklinik, Josef-Schneider-Str. 2, 97080
Würzburg
Fragestellung: Körperliche Aktivität und Sport werden bei
Mukoviszidose zunehmend therapeutisch eingesetzt. Ziel dieser
Studie war, die Prävalenz von belastungsinduzierter Hypxämie
und Herzrhythmusstörungen bei Mukoviszidosepatienten im
Rahmen einer standardisierten Belastung zu erfassen.
Methodik: In diese retrospektive Studie wurden alle zwischen
dem Jahr 2000 und 2006 in Würzburg spiroergometrisch mit
einem progressiven, kontinuierlichen Fahrradbelastungspro-
gramm untersuchten Patienten mit Mukoviszidose aufgenom-
men. Bei Patienten mit mehreren Untersuchungen wurde jeweils
nur die aktuellste ausgewählt. Insgesamt gingen die Daten von
68 Patienten im Alter von 12 bis 41 Jahren (33 Frauen,
35 Männer, FEV1 22–121%, Spitzensauerstoffaufnahme 12,1–
54,8 ml/kg/min) in die Studie ein. Die maximale Herzfrequenz
und der respiratorischeQuotient als Zeichen einer ausreichenden
Belastung lagen bei 176,5±15,7 min−1 bzw. 1,20±0,17. Die
Patienten wurden vor und während der Belastung mittels 12-
Kanal-EKG und Pulsoxymeter mit Stirnsensor (Nellcor®
Reflectance Oxygen Sensor RS-10) überwacht.
Ergebnisse: Bei 22 Patienten (=32%) fiel die O2-Sättigung
bei Belastung um mehr als 4%, bei 16 Patienten unter 90%. Der
Abfall der O2-Sättigung bzw. die Sättigung bei maximaler
Belastung korrelierten mit der FEV1 (r=0,56 bzw. r=0,65), es
kam jedoch auch bei einem Patienten mit einer FEV1 von 103%
zu einem Sättigungsabfall N4%, bei einem weiteren Patienten
mit einer FEV1 von 69% fiel die Sättigung unter 90%. 5
Patienten (7%) entwickelten belastungsinduzierte ventrikuläre
Extrasystolen (Alter 16,7–35,7 Jahre, FEV1 22,3–69,0%, Start
bei Herzfrequenz 103–167 min−1 bzw. Sättigung bei 86–95%).
Bei diesen Patienten zeigte sich in der Echokardiographie eine
Rechtsherzbelastung. Bei 2 weiteren Patienten konnten Rhyth-
musstörungen in Ruhe festgestellt werden, die unter Belastung
verschwanden (z.B. so genannte benigne ventrikuläre
Extrasystolen).
Diskussion: Patienten mit Mukoviszidose und insbesondere
solche mit einer schlechteren Lungenfunktion haben ein erhöhtes
Risiko für einen belastungsbedingten Abfall der O2-Sättigung
sowie - besonders bei Rechtsbelastung und belastungsassoziiertem
Abfall der O2-Sättigung - belastungsinduzierte ventrikuläre
Rhythmusstörungen.
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mit Mukoviszidose, die eine eingeschränkte Lungenfunktion
aufweisen, regelmäßig zur Erfassung von belastungsinduzierten
Komplikationen durchgeführt werden. Weiterhin kann die im
Rahmen der Ergometrie definierte Herzfrequenz, bei der es zur
Hypoxämie bzw. Rhythmusstörung kommt, als Obergrenze für
die Intensität sportlicher Aktivität genutzt werden.
Data was presented as oral presentation at the 8th annual
meeting of the Society of Pediatric Sports Medicine (Gesellschaft
für Pädiatrische Sportmedizin) in Basel/Switzerland in February
2008.
Belastungsinduzierte Hypoxämie und Herzrhythmusstörungen
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Fragestellung: Körperliche Aktivität und Sport spielen in der
Therapie der Mukoviszidose zunehmend eine wichtige Rolle.
Ziel dieser Studie war es, die Prävalenz von belastungsindu-
zierter Hypoxämie und Herzrhythmusstörungen zu erfassen
sowie mögliche Vorhersagekriterien für deren Auftreten zu
identifizieren.
Methodik: 75 Patienten mit Mukoviszidose (12–41 Jahre alt)
wurden spiroergometrisch unter pulsoxymetrischer und EKG-
Kontrolle untersucht. Die Analyse der Vorhersagekriterien
erfolgte mittels multipler linearer Regression.
Ergebnisse: Bei 17 Patienten (23%) fiel die Sauerstoffsättigung
bei maximaler Belastung (SpO2max) unter 90%, davon bei 4
Patienten unter 80%. Sowohl FEV1 (forced expiratory volume in
1 s) als auch die Sauerstoffsättigung in Ruhe (SpO2Ruhe) wiesen
signifikante Zusammenhänge mit der Sauerstoffsättigung unter
Belastung auf (r=0,66 bzw. r=0,71). In der Regressionsana-
lyse verhielt sich die Sauerstoffsättigung bei maximaler
Belastung unabhängig zum Ruhewert sowie zu den Werten
der Lungenfunktion.
5 Patienten entwickelten unter Belastung ventrikuläre
Extrasystolen. Diese Patienten hatten eine signifikant niedrigere
Sauerstoffsättigung (pb0.05) sowohl in Ruhe als auch unter
Belastung.
Schlussfolgerung: Trotz der Tendenz, dass Patienten mit
niedrigerem FEV1 und niedrigerer SpO2Ruhe eher unter
Hypoxämie bzw. Herzrhythmusstörungen litten, war im Indi-
viudalfall keine klare Vorhersage möglich. Deshalb sind
Belastungsuntersuchungen die einzige Möglichkeit, belastung-
sinduzierte Hypoxämie und Herzrhythmusstörungen sicher zu
identifizieren.
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